Hesitation in Implementing Heart Failure Drugs and Disparities in Usage

The chapter addresses concerns around hyperkalemia and clinical inertia hindering the adoption of MRAs in heart failure management, despite existing tools to control potassium levels. Disparities in treatment usage among various demographics are highlighted, shedding light on the overall low utilization of effective therapies.